A M Bogardus

838 total citations
8 papers, 682 citations indexed

About

A M Bogardus is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A M Bogardus has authored 8 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in A M Bogardus's work include Receptor Mechanisms and Signaling (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Neuropeptides and Animal Physiology (3 papers). A M Bogardus is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Neuropeptides and Animal Physiology (3 papers). A M Bogardus collaborates with scholars based in United States, Ireland and Czechia. A M Bogardus's co-authors include Karen M. Kedzie, Kristen L. Pierce, John E. Donello, John W. Regan, Craig Fairbairn, Thomas J. Bailey, D.F. Woodward, Daniel W. Gil, Elizabeth WoldeMussie and David F. Woodward and has published in prestigious journals such as Nucleic Acids Research, Journal of Bacteriology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A M Bogardus

8 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A M Bogardus United States 7 333 255 134 119 117 8 682
D.F. Woodward United States 12 393 1.2× 223 0.9× 114 0.9× 112 0.9× 100 0.9× 26 856
Julie Y. Crider United States 21 285 0.9× 398 1.6× 79 0.6× 173 1.5× 588 5.0× 36 1.1k
Atsushi Ichikawa Japan 8 315 0.9× 291 1.1× 132 1.0× 103 0.9× 8 0.1× 9 660
Yu‐Wen E. Chang United States 15 136 0.4× 349 1.4× 85 0.6× 86 0.7× 9 0.1× 20 664
R.A. Akhtar United States 11 38 0.1× 433 1.7× 41 0.3× 123 1.0× 83 0.7× 17 616
Naj Sharif United States 13 72 0.2× 261 1.0× 16 0.1× 104 0.9× 294 2.5× 24 636
Sina Bahmanyar United States 12 73 0.2× 415 1.6× 31 0.2× 116 1.0× 79 0.7× 12 790
Christian Kamp Nielsen Sweden 11 119 0.4× 386 1.5× 89 0.7× 65 0.5× 6 0.1× 12 687
Rainer Metzger Germany 16 210 0.6× 785 3.1× 127 0.9× 169 1.4× 4 0.0× 22 1.6k
A L United States 9 33 0.1× 461 1.8× 20 0.1× 217 1.8× 271 2.3× 11 862

Countries citing papers authored by A M Bogardus

Since Specialization
Citations

This map shows the geographic impact of A M Bogardus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Bogardus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Bogardus more than expected).

Fields of papers citing papers by A M Bogardus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Bogardus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Bogardus. The network helps show where A M Bogardus may publish in the future.

Co-authorship network of co-authors of A M Bogardus

This figure shows the co-authorship network connecting the top 25 collaborators of A M Bogardus. A scholar is included among the top collaborators of A M Bogardus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Bogardus. A M Bogardus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Woodward, David F., Achim H.‐P. Krauss, Yuanbo Liang, et al.. (2003). Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024). Journal of Pharmacology and Experimental Therapeutics. 305(2). 772–785. 115 indexed citations
2.
Gil, Daniel W., et al.. (1997). Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation.. PubMed. 38(7). 1434–42. 83 indexed citations
3.
Woodward, David F., A M Bogardus, John E. Donello, et al.. (1995). Molecular Characterization and Ocular Hypotensive Properties of the Prostanoid EP 2 Receptor. Journal of Ocular Pharmacology and Therapeutics. 11(3). 447–454. 24 indexed citations
4.
Regan, John W., Thomas J. Bailey, John E. Donello, et al.. (1994). Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini. British Journal of Pharmacology. 112(2). 377–385. 85 indexed citations
5.
Regan, John W., Thomas J. Bailey, Kristen L. Pierce, et al.. (1994). Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.. Molecular Pharmacology. 46(2). 213–220. 350 indexed citations
6.
Gil, Diana, et al.. (1993). Muscarinic receptors in human ciliary muscle identified by polymerase chain reaction (PCR) and immunoprecipitation. Life Sciences. 52(5-6). 573–573. 1 indexed citations
7.
Bell, Jeffrey R., et al.. (1985). A newcopia-like transposable element found in aDrosophilarDNA gene unit. Nucleic Acids Research. 13(11). 3861–3871. 13 indexed citations
8.
Bogardus, A M, et al.. (1983). Mapping of chromosomal IS5 elements that mediate type II F-prime plasmid excision in Escherichia coli K-12. Journal of Bacteriology. 153(1). 395–407. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026